Cyclophosphamide/Epirubicin/Pembrolizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cyclophosphamide and epirubicin followed by pembrolizumab, used as a neoadjuvant or adjuvant treatment for HER-2 (EGFR2; ErbB2)-negative and hormone receptor-negative breast cancer.

**Synonyms:** - Cyclophosphamide-Epirubicin-Pembrolizumab - Cyclophosphamide-Epirubicin-Pembrolizumab Regimen - Cyclophosphamide/Epirubicin/Pembrolizumab - EC Followed by Pembrolizumab Regimen - EC Plus Pembrolizumab Regimen - EC-Pembrolizumab Regimen - EC/Pembrolizumab Regimen - Ellence/Cytoxan Followed by Keytruda Regimen - Epirubicin/Cyclophosphamide Followed by Pembrolizumab Regimen